Health & Biotech Exopharm identifies two new lead programs as exosomes gain prominence in gene therapy October 13, 2022 Special Report: Exopharm’s technology has put the company in a leadership-position in both naïve exosomes and engineered exosomes as it… Weed Week: US looks to decriminalise cannabis and Victoria Greens say legal weed could mean $1.21bn in revenue October 13, 2022 The US could potentially reclassify cannabis, and the Victorian Greens want to legalise and tax the drug at 30%. ASX Health Stocks: Cynata races ahead after getting green light for diabetic foot ulcer clinical trial October 12, 2022 Cynata Therapeutics (ASX:CYP) announced that an independent review of Cynata’s diabetic foot ulcer (DFU) clinical trial has been completed. Clinical Trials 101: How to know your placebos from blinded studies October 12, 2022 Understanding the clinical trial process is crucial for investing in biotechnology companies so here's part one of our breakdown. Wellnex: This is the summer when Australia will discover the real cannabidiol (CBD) opportunity October 12, 2022 Special Report: If you haven’t heard of Aussie-listed Wellnex Life (ASX: WNX) yet, you’re going to in the lead up to… This transport company is saving time and money with Skin Elements all-natural disinfectant October 11, 2022 Special Report: Local transport company Thomson Coachlines has capitalized on Skin Elements new all-natural disinfectant to save time and money… Wellnex says it is ready to get ‘product on Aussie shelves by Xmas’ after deal opens giant new med-cannabis market October 10, 2022 Special Report: The specialist Aussie health & wellness brand, Wellnex Life (ASX: WNX), has just opened a vast new, $500… EZZ Life Science Holdings takes big leaps for future global growth October 10, 2022 Special Report: Despite challenging macroeconomic conditions and continued fallout from the COVID-19 pandemic during FY22, one ASX-listed life science company… Another breakthrough for Zantrene as Race Oncology significantly expands its addressable market October 10, 2022 Special Report: A new breakthrough formulation for Race Oncology’s lead asset drug Zantrene means it has significantly increased its potential… Creso ready to capitalise on potential US reclassification of cannabis October 7, 2022 Special Report: Big news out of the US today with President Joe Biden announcing plans to pardon all federal offenses… Next» « Previous